Although PD-1 is the most well-known exhaustion marker in chronic infection and cancer, and above, we have provided evidence of its ability to inhibit memory CD8+ T cell responses, studies revealed that healthy human adults harbor populations of CD8+ effector memory T cells that have high levels of PD-1 on their surface, and that these cells were less terminally differentiated (38). This evidence concerns the gene CD8A and cancer.